Morgan Stanley analyst David Phung maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $551 to $560.
Morgan Stanley analyst David Phung maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $551 to $560.